日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

每日两次服用固定剂量复方比克替拉韦-恩曲他滨-替诺福韦艾拉酚胺治疗利福平类结核病期间合并HIV感染(INSIGHT研究):一项2b期、开放标签、随机、非对照试验

Naidoo, Anushka; Naidoo, Kogieleum; Letsoalo, Marothi P; Wasmann, Roeland E; Dorse, Gillian; Perumal, Rubeshan; Moosa, Mahomed-Yunus S; Osuala, Emmanuella C; Boodhram, Resha; Chimukangara, Benjamin; Wiesner, Lubbe; Israelski, Dennis; Denti, Paolo; Rooney, James F; Dooley, Kelly E

A Pragmatic Approach to Handling Censored Data Below the Lower Limit of Quantification in Pharmacokinetic Modeling

药代动力学建模中处理低于定量下限的删失数据的实用方法

Wijk, Marie; Wasmann, Roeland E; Jacobson, Karen R; Svensson, Elin M; Denti, Paolo

Continuous visual stimulus tracking to quantify eye motility in spinocerebellar ataxia type 3

利用连续视觉刺激追踪量化脊髓小脑性共济失调3型患者的眼球运动

de Boer, M J; Wasmann, R A; Pott, J W R; Cornelissen, F W; Jansonius, N M

Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV

在感染艾滋病毒的非洲儿童中,利托那韦作为洛匹那韦、阿扎那韦或达芦那韦的增效剂的群体药代动力学研究

Tsirizani, Lufina; Waalewijn, Hylke; Szubert, Alexander; Mulenga, Veronica; Chabala, Chishala; Bwakura-Dangarembizi, Mutsa; Chitsamatanga, Moses; Rutebarika, Diana A; Musiime, Victor; Kasozi, Mariam; Lugemwa, Abbas; McIlleron, Helen M; Burger, David M; Gibb, Diana M; Colbers, Angela; Denti, Paolo; Wasmann, Roeland E

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study

南非接受利福平治疗的结核病儿童服用多替拉韦的药代动力学和安全性研究(ORCHID):一项前瞻性队列研究

Naidoo, Anushka; Waalewijn, Hylke; Naidoo, Kogieleum; Letsoalo, Marothi; Cromhout, Gabriela; Sewnarain, Leora; Mosia, Nozibusiso R; Osuala, Emmanuella C; Wiesner, Lubbe; Wasmann, Roeland E; Denti, Paolo; Dooley, Kelly E; Archary, Moherndran

A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing

基于纳米孔测序的药物基因组学检测方法用于结核病药物个性化给药

Verma, Renu; da Silva, Kesia Esther; Rockwood, Neesha; Wasmann, Roeland E; Yende, Nombuso; Song, Taeksun; Kim, Eugene; Denti, Paolo; Wilkinson, Robert J; Andrews, Jason R

Population pharmacokinetics of rifabutin among HIV/TB co-infected children on lopinavir/ritonavir-based antiretroviral therapy

在接受洛匹那韦/利托那韦类抗逆转录病毒治疗的HIV/结核病合并感染儿童中,利福布汀的群体药代动力学研究

Semere Gebreyesus, Manna; Wasmann, Roeland E; McIlleron, Helen; Oladokun, Regina; Okonkwo, Prosper; Wiesner, Lubbe; Denti, Paolo; Rawizza, Holly E

Characteristics of autosomal dominant WFS1-associated optic neuropathy and its comparability to OPA1-associated autosomal dominant optic atrophy

常染色体显性遗传WFS1相关视神经病变的特征及其与OPA1相关常染色体显性遗传视神经萎缩的比较

de Muijnck, Cansu; Haer-Wigman, Lonneke; van Everdingen, Judith A M; Lushchyk, Tanya; Heutinck, Pam A T; van Dooren, Marieke F; Kievit, Anneke J A; Verhoeven, Virginie J M; Simon, Marleen E H; Wasmann, Rosemarie A; Notting, Irene C; De Baere, Elfride; Walraedt, Sophie; De Zaeytijd, Julie; Van den Broeck, Filip; Leroy, Bart P; Boon, Camiel J F; van Genderen, Maria M

Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV

达芦那韦/利托那韦每日一次用于非洲HIV感染儿童二线治疗的药代动力学研究

Tsirizani, Lufina; Mohsenian Naghani, Shaghayegh; Waalewijn, Hylke; Szubert, Alexander; Mulenga, Veronica; Chabala, Chishala; Bwakura-Dangarembizi, Mutsa; Chitsamatanga, Moses; Rutebarika, Diana A; Musiime, Victor; Kasozi, Mariam; Lugemwa, Abbas; Monkiewicz, Lara N; McIlleron, Helen M; Burger, David M; Gibb, Diana M; Denti, Paolo; Wasmann, Roeland E; Colbers, Angela

Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass

在接受体外循环心脏手术的南非儿童中优化头孢唑林的剂量

Gebreyesus, Manna Semere; Dresner, Alexandra; Wiesner, Lubbe; Coetzee, Ettienne; Verschuuren, Tess; Wasmann, Roeland; Denti, Paolo